Valuing pharmaceuticals in the U.S.
Respect for individual patient needs should be at the heart of evaluating medical innovation. We study and develop patient-centered and clinically-driven approaches to value assessment.
The objective: Ensure that methods and approaches to valuing pharmaceuticals reflect the holistic benefits to patients, the healthcare system and society.
The objective: Ensure that methods and approaches to valuing pharmaceuticals reflect the holistic benefits to patients, the healthcare system and society.
Our research
Understanding state Medicaid spending on prescription drugs
This analysis demonstrates that state Medicaid programs are estimated to be spending near or below the national average on prescription drugs.
A review of heterogeneity in comparative economic analysis
With specific considerations for the decentralized U.S. setting and patient-centered care